Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer

Matsuishi, K; Miyamoto, Y; Hiyoshi, Y; Tokunaga, R; Imai, K; Hayashi, H; Yamashita, Y; Yoshida, N; Baba, H

SURGICAL CASE REPORTS, 2020; 6 (1):

Abstract

Background Advancements in chemotherapy for metastatic colorectal cancer (mCRC) have improved long-term outcomes, and median survival currently exceed......

Full Text Link